Literature DB >> 24532324

Excellent response to a ketogenic diet in a patient with alternating hemiplegia of childhood.

Anne Roubergue1, Bertrand Philibert, Agnès Gautier, Alice Kuster, Karine Markowicz, Thierry Billette de Villemeur, Sandrine Vuillaumier-Barrot, Sophie Nicole, Emmanuel Roze, Diane Doummar.   

Abstract

UNLABELLED: Alternating hemiplegia of childhood (AHC) is a rare disorder caused by heterozygous mutations in ATP1A3. AHC is associated with early-onset plegic and tonic/dystonic attacks and permanent neurologic deficits. Attacks tend to persist through life. Flunarizine therapy occasionally reduces the severity, duration and frequency of attacks. A ketogenic diet/modified Atkins diet (KD/MAD) can attenuate paroxysmal movement disorders associated with GLUT1 deficiency syndrome (GLUT1DS), but there are no reports on the effect of KD/MAD in AHC. We describe the case of a young girl with AHC who had tonic/dystonic and plegic attacks, mostly triggered by exercise, together with mild permanent dystonia and mental retardation. Her family had a history of dominant (three affected generations) paroxysmal exercise-induced dystonia. A history of plegic attacks that ceased after childhood was retraced from the medical records of the three affected adults, leading to the diagnosis of familial AHC due to ATP1A3 p.Asp923Asn mutation (Roubergue et al 2013). KD/MAD was considered for the proband when she was 3½ years old, following initial misdiagnosis of GLUT1DS. MAD, a KD variant, was chosen because it is easier to manage than KD and is similarly effective to KD in most GLUT1DS patients. MAD resulted in complete disappearance of the attacks during 15 months of follow-up.
CONCLUSIONS: A modified Atkins diet had a sustained beneficial effect on attacks associated with AHC. Although preliminary, this observation suggests that a ketogenic diet might be a therapeutic option for paroxysmal disorders in some patients with alternating hemiplegia of childhood.

Entities:  

Year:  2014        PMID: 24532324      PMCID: PMC4270868          DOI: 10.1007/8904_2013_292

Source DB:  PubMed          Journal:  JIMD Rep        ISSN: 2192-8304


  28 in total

1.  Evidence of a non-progressive course of alternating hemiplegia of childhood: study of a large cohort of children and adults.

Authors:  Eleni Panagiotakaki; Giuseppe Gobbi; Brian Neville; Friedrich Ebinger; Jaume Campistol; Sona Nevsímalová; Laura Laan; Paul Casaer; Georg Spiel; Melania Giannotta; Carmen Fons; Miriam Ninan; Guenter Sange; Tsveta Schyns; Rosaria Vavassori; Dominique Poncelin; Alexis Arzimanoglou
Journal:  Brain       Date:  2010-10-24       Impact factor: 13.501

2.  Rapid-onset dystonia-parkinsonism in a child with a novel atp1a3 gene mutation.

Authors:  I A Anselm; K J Sweadner; S Gollamudi; L J Ozelius; B T Darras
Journal:  Neurology       Date:  2009-08-04       Impact factor: 9.910

3.  The multiple faces of the ATP1A3-related dystonic movement disorder.

Authors:  Anne Roubergue; Emmanuel Roze; Sandrine Vuillaumier-Barrot; Marie-Joséphine Fontenille; Aurélie Méneret; Marie Vidailhet; Bertrand Fontaine; Diane Doummar; Bertrand Philibert; Florence Riant; Sophie Nicole
Journal:  Mov Disord       Date:  2013-03-08       Impact factor: 10.338

4.  Flunarizine in alternating hemiplegia in childhood.

Authors:  P Casaer; M Azou
Journal:  Lancet       Date:  1984-09-08       Impact factor: 79.321

Review 5.  Ketogenic diet.

Authors:  Radhika Dhamija; Susan Eckert; Elaine Wirrell
Journal:  Can J Neurol Sci       Date:  2013-03       Impact factor: 2.104

6.  A modified Atkins diet is promising as a treatment for glucose transporter type 1 deficiency syndrome.

Authors:  Yasushi Ito; Hirokazu Oguni; Susumu Ito; Miyako Oguni; Makiko Osawa
Journal:  Dev Med Child Neurol       Date:  2011-04-18       Impact factor: 5.449

Review 7.  Alternating hemiplegia of childhood.

Authors:  M Bourgeois; J Aicardi; F Goutières
Journal:  J Pediatr       Date:  1993-05       Impact factor: 4.406

8.  Alternating hemiplegia of childhood: a study of 10 patients and results of flunarizine treatment.

Authors:  K Silver; F Andermann
Journal:  Neurology       Date:  1993-01       Impact factor: 9.910

9.  De novo mutations in ATP1A3 cause alternating hemiplegia of childhood.

Authors:  Erin L Heinzen; Kathryn J Swoboda; Yuki Hitomi; Fiorella Gurrieri; Sophie Nicole; Boukje de Vries; F Danilo Tiziano; Bertrand Fontaine; Nicole M Walley; Sinéad Heavin; Eleni Panagiotakaki; Stefania Fiori; Emanuela Abiusi; Lorena Di Pietro; Matthew T Sweney; Tara M Newcomb; Louis Viollet; Chad Huff; Lynn B Jorde; Sandra P Reyna; Kelley J Murphy; Kevin V Shianna; Curtis E Gumbs; Latasha Little; Kenneth Silver; Louis J Ptáček; Joost Haan; Michel D Ferrari; Ann M Bye; Geoffrey K Herkes; Charlotte M Whitelaw; David Webb; Bryan J Lynch; Peter Uldall; Mary D King; Ingrid E Scheffer; Giovanni Neri; Alexis Arzimanoglou; Arn M J M van den Maagdenberg; Sanjay M Sisodiya; Mohamad A Mikati; David B Goldstein
Journal:  Nat Genet       Date:  2012-07-29       Impact factor: 38.330

10.  Paroxysmal exercise-induced dyskinesia and epilepsy is due to mutations in SLC2A1, encoding the glucose transporter GLUT1.

Authors:  Arvid Suls; Peter Dedeken; Karolien Goffin; Hilde Van Esch; Patrick Dupont; David Cassiman; Judith Kempfle; Thomas V Wuttke; Yvonne Weber; Holger Lerche; Zaid Afawi; Wim Vandenberghe; Amos D Korczyn; Samuel F Berkovic; Dana Ekstein; Sara Kivity; Philippe Ryvlin; Lieve R F Claes; Liesbet Deprez; Snezana Maljevic; Alberto Vargas; Tine Van Dyck; Dirk Goossens; Jurgen Del-Favero; Koen Van Laere; Peter De Jonghe; Wim Van Paesschen
Journal:  Brain       Date:  2008-06-24       Impact factor: 13.501

View more
  7 in total

Review 1.  Diagnosis and Treatment of Alternating Hemiplegia of Childhood.

Authors:  Melanie Masoud; Lyndsey Prange; Jeffrey Wuchich; Arsen Hunanyan; Mohamad A Mikati
Journal:  Curr Treat Options Neurol       Date:  2017-02       Impact factor: 3.598

Review 2.  The expanding spectrum of neurological phenotypes in children with ATP1A3 mutations, Alternating Hemiplegia of Childhood, Rapid-onset Dystonia-Parkinsonism, CAPOS and beyond.

Authors:  Matthew T Sweney; Tara M Newcomb; Kathryn J Swoboda
Journal:  Pediatr Neurol       Date:  2014-10-13       Impact factor: 3.372

3.  Transgenic rescue of phenotypic deficits in a mouse model of alternating hemiplegia of childhood.

Authors:  Greer S Kirshenbaum; James Dachtler; John C Roder; Steven J Clapcote
Journal:  Neurogenetics       Date:  2015-10-13       Impact factor: 2.660

Review 4.  The Structure and Function of the Na,K-ATPase Isoforms in Health and Disease.

Authors:  Michael V Clausen; Florian Hilbers; Hanne Poulsen
Journal:  Front Physiol       Date:  2017-06-06       Impact factor: 4.566

Review 5.  The Influence of Na(+), K(+)-ATPase on Glutamate Signaling in Neurodegenerative Diseases and Senescence.

Authors:  Paula F Kinoshita; Jacqueline A Leite; Ana Maria M Orellana; Andrea R Vasconcelos; Luis E M Quintas; Elisa M Kawamoto; Cristoforo Scavone
Journal:  Front Physiol       Date:  2016-06-02       Impact factor: 4.566

6.  More Than a Decade of Misdiagnosis of Alternating Hemiplegia of Childhood with Catastrophic Outcome.

Authors:  Hussein Algahtani; Bashair Ibrahim; Bader Shirah; Ahmad Aldarmahi; Ahad Abdullah
Journal:  Case Rep Med       Date:  2017-08-16

7.  A randomized, controlled, double-blind, crossover trial of triheptanoin in alternating hemiplegia of childhood.

Authors:  Elodie Hainque; Samantha Caillet; Sandrine Leroy; Constance Flamand-Roze; Isaac Adanyeguh; Fanny Charbonnier-Beaupel; Maryvonne Retail; Benjamin Le Toullec; Mariana Atencio; Sophie Rivaud-Péchoux; Vanessa Brochard; Florence Habarou; Chris Ottolenghi; Florence Cormier; Aurélie Méneret; Marta Ruiz; Mohamed Doulazmi; Anne Roubergue; Jean-Christophe Corvol; Marie Vidailhet; Fanny Mochel; Emmanuel Roze
Journal:  Orphanet J Rare Dis       Date:  2017-10-02       Impact factor: 4.123

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.